Previous close | 21.20 |
Open | 20.40 |
Bid | 0.00 x 10000 |
Ask | 0.00 x 10000 |
Day's range | 19.90 - 20.40 |
52-week range | 18.70 - 70.50 |
Volume | |
Avg. volume | 0 |
Market cap | 1.07B |
Beta (5Y monthly) | 0.30 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DUBLIN, May 08, 2024--Prothena today reported financial results for the first quarter of 2024 and provided business highlights
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.